Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-17

FDA Approved: RUFINAMIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' generic Rufinamide (ANDA204964) for the treatment of seizures associated with Lennox-Gastaut syndrome, expanding access …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)